Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets

  • Expert Opin Ther Targets. 2022 Mar;26(3):187-192. doi: 10.1080/14728222.2022.2040017.
Julian S Rechberger  1  2 ,  Cody L Nesvick  2 ,  David J Daniels  2
Affiliations
  • 1. Mayo Clinic Graduate School of Biomedical Sciences, Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN, United States.
  • 2. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
PMID: 35142587 DOI: 10.1080/14728222.2022.2040017
Keywords
ATRT; Atypical teratoid rhabdoid tumor; BAF; SMARCB1; SWI/SNF; enhancer; epigenomics; rhabdoid tumor; targeted therapeutics.